Supply chain leaders at pharmaceutical and biotech companies often lack timely answers to basic questions: what inventory exists, where it sits, and when it expires. The challenge appears at every scale-from global enterprises with thousands of SKUs to clinical-stage and pre-commercial companies preparing for launch.
Approach
- Obtain inventory status from each supply chain node at month-end
- Aggregate key inventory data elements into a central repository
- Link the repository to a reporting engine (Power BI, Tableau, or Excel)
- Establish a recurring review and inventory adjustment cadence (as little as 30 minutes per month once in control)
Results
- Horizon view Expiry forecasting across portfolio and nodes-enabling reaction time before stock is at risk
- Finance alignment Improved confidence in inventory position and working-capital reporting
- Program protection Reduced risk of near-term expiry, short supply of bulk material, and component shortages derailing trials or launches
Segment: Pharma & Biotech · Services: supply-chain-planning, supply-chain-integration, process-excellence